Search research articles
Contact Us
Filters
Showing results (71-80 of 138) with videos related to
Page
of 14
Sort By:
Arzneimittel-Forschung
|
September 14, 1999
[The significance of estrogen metabolism for hormone-dependent neoplasms from the clinical-pharmacological viewpoint]
T H Lippert, H Seeger, A O Mueck
Life Sciences
|
September 30, 1999
Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures
H Seeger, A O Mueck, T H Lippert
International Journal of Clinical Pharmacology and Therapeutics
|
August 26, 1998
The inhibitory effect of endogenous estrogen metabolites on copper-mediated in vitro oxidation of LDL
H Seeger, A O Mueck, T H Lippert
Clinical and Experimental Obstetrics & Gynecology
|
December 5, 1998
Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
A O Mueck, H Seeger, T H Lippert
Zentralblatt Fur Gynakologie
|
November 25, 2003
[Estrogen-dependent neoplasia - what is the significance of estradiol metabolites]
A O Mueck, H Seeger, T H Lippert
International Journal of Clinical Pharmacology and Therapeutics
|
June 6, 2000
Fluvastatin increases prostacyclin and decreases endothelin production by human umbilical vein endothelial cells
H Seeger, A O Mueck, T H Lippert
Steroids
|
July 19, 2000
The impact of endogenous estradiol metabolites on carcinogenesis
T H Lippert, H Seeger, A O Mueck
Zentralblatt Fur Gynakologie
|
November 26, 1999
[The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause]
T H Lippert, H Seeger, A O Mueck
British Journal of Clinical Pharmacology
|
May 3, 2000
Is the use of conjugated equine oestrogens in hormone replacement therapy still appropriate?
T H Lippert, A O Mueck, H Seeger
Gynakologische Rundschau
|
January 1, 1973
[Therapy of hypovolemia in EPH-gestoses using plasma expanders with central venous pressure control]
T H Lippert, S E Cloeren, M Hinselmann
Page
of 14
Search research articles
Search
Showing results (71-80 of 138) with videos related to
Sort By:
Page
of 14
Arzneimittel-Forschung
|
September 14, 1999
[The significance of estrogen metabolism for hormone-dependent neoplasms from the clinical-pharmacological viewpoint]
T H Lippert, H Seeger, A O Mueck
Life Sciences
|
September 30, 1999
Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures
H Seeger, A O Mueck, T H Lippert
International Journal of Clinical Pharmacology and Therapeutics
|
August 26, 1998
The inhibitory effect of endogenous estrogen metabolites on copper-mediated in vitro oxidation of LDL
H Seeger, A O Mueck, T H Lippert
Clinical and Experimental Obstetrics & Gynecology
|
December 5, 1998
Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
A O Mueck, H Seeger, T H Lippert
Zentralblatt Fur Gynakologie
|
November 25, 2003
[Estrogen-dependent neoplasia - what is the significance of estradiol metabolites]
A O Mueck, H Seeger, T H Lippert
International Journal of Clinical Pharmacology and Therapeutics
|
June 6, 2000
Fluvastatin increases prostacyclin and decreases endothelin production by human umbilical vein endothelial cells
H Seeger, A O Mueck, T H Lippert
Steroids
|
July 19, 2000
The impact of endogenous estradiol metabolites on carcinogenesis
T H Lippert, H Seeger, A O Mueck
Zentralblatt Fur Gynakologie
|
November 26, 1999
[The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause]
T H Lippert, H Seeger, A O Mueck
British Journal of Clinical Pharmacology
|
May 3, 2000
Is the use of conjugated equine oestrogens in hormone replacement therapy still appropriate?
T H Lippert, A O Mueck, H Seeger
Gynakologische Rundschau
|
January 1, 1973
[Therapy of hypovolemia in EPH-gestoses using plasma expanders with central venous pressure control]
T H Lippert, S E Cloeren, M Hinselmann
Page
of 14